FREE Case Review (866) 588-0600

California Belviq Attorney
Weight Loss Drug Linked to Cancer

The U.S. Food and Drug Administration (FDA) has issued a nationwide recall for the weight-loss drugs Belviq and Belviq XR, manufacturer Eisai, Inc., after a placebo controlled clinical trial found elevated cancer risk for several types of cancer including lung cancer, pancreatic cancer and colorectal cancer.
Awards & recognition

Free Confidential Belviq Lawsuit Review
Patients taking the weight loss drug Belviq or Belviq XR who were diagnosed with cancer in California should contact our dangerous drugs law firm immediately for legal action. You may be entitled to financial compensation by filing a Belviq cancer lawsuit against the drug manufacturer Eisai Inc. and a Belviq cancer attorney can help. Please click the button below for a Free Consultation or call our Belviq lawyers about your potential claim toll-free 24 hrs/day by dialing (866) 588-0600.

Start My Free Belviq Lawsuit Review

What is Belviq?

Belviq (Lorcaserin) is a prescription-only medication, manufactured by Eisai, Inc. and distributed by Arena Pharmaceuticals, which gained FDA approval in 2012. It was primarily prescribed for overweight and obese patients struggling to lose weight.

Its active ingredient, lorcaserin, facilitated weight loss in patients by altering signals in the brain that trigger appetite and hunger. These simple chemical changes created by Belviq use increased feelings of fullness among patients – convincing them to reduce caloric intake and consume much less than they normally would.

Related Article: Belviq Lawsuit (Diet Drug Linked to Cancer)

Are There Different Types of Belviq?

Belviq was available to patients in two different forms:

  • Belviq
  • Belviq XR

The standard form of Belviq was a 10mg tablet that patients were to take twice a day, while Belviq XR was their extended-release version, a much higher dose than required only a single daily dose.

Choose our lawyers

Have you or a loved one been injured in an accident due to the negligence of others?

What’s the Problem with Belviq Weight Loss Drugs

One of the conditions set in place by the FDA was that Arena Pharmaceuticals would have to run additional safety studies to ensure the drug wasn’t overly dangerous. These tests ran from 2013 to 2018 and consisted of randomized, double-blind, placebo-controlled trials. In those five years, about 12,000 people participated in the trials.

The tests showed that patients taking Belviq were more often diagnosed with cancer than those who took a placebo. In fact, one additional person per 470 taking Belviq for at least a year was diagnosed with cancer.

After these trials, the FDA decided the risks of lorcaserin outweighed its benefits. In 2020, the FDA asked Eisai to withdraw Belviq, and they complied.

Related Articles:

Weight Loss Drug Side Effects

Both Belviq and Belviq XR weight loss drugs have been linked to the following cancer risks:

  • Colorectal Cancer
  • Lung Cancer
  • Colon Cancer
  • Pancreatic Cancer
  • Breast Cancer
  • Liver cancer
  • Cardiovascular Events
  • Heart Attack
  • Stroke
  • Hypertension
  • Heart Valve Damage
  • Serotonin Syndrome

Related Articles:

See related dangerous drugs lawsuits our lawyers are accepting.

Get a Free Belviq Lawsuit Evaluation With Our Lawyers

The Dangerous Drug Litigation Group at our law firm is an experienced team of state court lawyers that focus on the representation of Belviq patients. We are handling individual Belviq Lawsuits nationwide and currently accepting new cancer diagnosis cases in all 50 states.

Belviq users who got cancer after taking Belviq or another weight loss drug should contact our law firm immediately to schedule a free consultation. You may be entitled to a settlement by filing a Belviq lawsuit against the drug manufacturer and our Belviq attorneys can help.

Free Confidential Case Evaluation

Verified 100% Secure SiteTo contact us for a free review of your potential case, please fill out the form below or call us toll free 24 hrs/day by dialing: (866) 588-0600.